{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:13:50Z","timestamp":1791148430335,"version":"4.1.0"},"reference-count":37,"publisher":"Spandidos Publications","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.3892\/ijmm.2015.2142","type":"journal-article","created":{"date-parts":[[2015,3,17]],"date-time":"2015-03-17T12:43:42Z","timestamp":1426596222000},"page":"1374-1380","source":"Crossref","is-referenced-by-count":29,"title":["Decreased semaphorin 3A expression is associated with a poor prognosis in patients with epithelial ovarian carcinoma"],"prefix":"10.3892","volume":"35","author":[{"given":"HAIYAN","family":"JIANG","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LEI","family":"QI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FEIRAN","family":"WANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHICHAO","family":"SUN","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ZHONGWEI","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QINGHUA","family":"XI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2015,3,17]]},"reference":[{"key":"key20180107230423_b1-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"10","DOI":"10.3322\/caac.20138","article-title":"Cancer statistics, 2012","volume":"62","author":"Siegel","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"key20180107230423_b2-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1097\/IGC.0b013e31823c6efd","article-title":"Antiangiogenic agents in combination with chemotherapy for the treatment of epithelial ovarian cancer","volume":"22","author":"Teoh","year":"2012","journal-title":"Int J Gynecol Cancer"},{"key":"key20180107230423_b3-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ygyno.2011.02.013","article-title":"A Gynecologic Oncology Group phase II trial of the protein kinase C-beta inhibitor, enzastaurin and evaluation of markers with potential predictive and prognostic value in persistent or recurrent epithelial ovarian and primary peritoneal malignancies","volume":"121","author":"Usha","year":"2011","journal-title":"Gynecol Oncol"},{"key":"key20180107230423_b4-ijmm-35-05-1374","first-page":"207","article-title":"Development of synthetic of peptide-functionalized liposome for enhanced targeted ovarian carcinoma therapy","volume":"8","author":"Wu","year":"2015","journal-title":"Int J Clin Exp Pathol"},{"key":"key20180107230423_b5-ijmm-35-05-1374","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1501735112","article-title":"Recurrent BCAM-AKT2 fusion gene leads to a constitutively activated AKT2 fusion kinase in high-grade serous ovarian carcinoma","author":"Kannan","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107230423_b6-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"3419","DOI":"10.3390\/ijms16023419","article-title":"Three-dimensional collagen type I matrix up-regulates nuclear isoforms of the microtubule associated protein tau implicated in resistance to Paclitaxel therapy in ovarian carcinoma","volume":"16","author":"Gurler","year":"2015","journal-title":"Int J Mol Sci"},{"key":"key20180107230423_b7-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1038\/onc.2010.127","article-title":"Genetic determinants at the interface of cancer and neurodegenerative disease","volume":"29","author":"Morris","year":"2010","journal-title":"Oncogene"},{"key":"key20180107230423_b8-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cell.2010.05.029","article-title":"Environmental and genetic activation of a brain-adipocyte BDNF\/leptin axis causes cancer remission and inhibition","volume":"142","author":"Cao","year":"2010","journal-title":"Cell"},{"key":"key20180107230423_b9-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ydbio.2005.12.048","article-title":"Molecular mechanisms of axon guidance","volume":"292","author":"Chilton","year":"2006","journal-title":"Dev Biol"},{"key":"key20180107230423_b10-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1126\/science.1072165","article-title":"Molecular mechanisms of axon guidance","volume":"298","author":"Dickson","year":"2002","journal-title":"Science"},{"key":"key20180107230423_b11-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1172\/JCI21378","article-title":"Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype","volume":"114","author":"Bielenberg","year":"2004","journal-title":"J Clin Invest"},{"key":"key20180107230423_b12-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"6167","DOI":"10.1158\/0008-5472.CAN-04-4309","article-title":"Proteolytic processing converts the repelling signal Sema3E into an inducer of invasive growth and lung metastasis","volume":"65","author":"Christensen","year":"2005","journal-title":"Cancer Res"},{"key":"key20180107230423_b13-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1038\/nrc2404","article-title":"The semaphorins: versatile regulators of tumour progression and tumour angiogenesis","volume":"8","author":"Neufeld","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"key20180107230423_b14-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"e3287","DOI":"10.1371\/journal.pone.0003287","article-title":"Successful inhibition of tumor development by specific class-3 semaphorins is associated with expression of appropriate semaphorin receptors by tumor cells","volume":"3","author":"Kigel","year":"2008","journal-title":"PLoS One"},{"key":"key20180107230423_b15-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/0008-5472.CAN-03-3090","article-title":"Semaphorin-3F is an inhibitor of tumor angiogenesis","volume":"64","author":"Kessler","year":"2004","journal-title":"Cancer Res"},{"key":"key20180107230423_b16-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/ATVBAHA.110.211920","article-title":"Systemic and targeted delivery of semaphorin 3A inhibits tumor angiogenesis and progression in mouse tumor models","volume":"31","author":"Casazza","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key20180107230423_b17-ijmm-35-05-1374","first-page":"3356","article-title":"Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models","volume":"119","author":"Maione","year":"2009","journal-title":"J Clin Invest"},{"key":"key20180107230423_b18-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"3086","DOI":"10.1128\/MCB.01652-09","article-title":"Semaphorin 3E initiates antiangiogenic signaling through plexin D1 by regulating Arf6 and R-Ras","volume":"30","author":"Sakurai","year":"2010","journal-title":"Mol Cell Biol"},{"key":"key20180107230423_b19-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.1158\/0008-5472.CAN-07-5408","article-title":"Semaphorin-3B is an angiogenesis inhibitor that is inactivated by furin-like pro-protein convertases","volume":"68","author":"Varshavsky","year":"2008","journal-title":"Cancer Res"},{"key":"key20180107230423_b20-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1084\/jem.20072509","article-title":"The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment","volume":"205","author":"Rolny","year":"2008","journal-title":"J Exp Med"},{"key":"key20180107230423_b21-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000232449","article-title":"Semaphorin3F down-regulates the expression of integrin alpha(v)beta3 and sensitizes multicellular tumor spheroids to chemotherapy via the neuropilin-2 receptor in vitro","volume":"55","author":"Zheng","year":"2009","journal-title":"Chemotherapy"},{"key":"key20180107230423_b22-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"3537","DOI":"10.1038\/onc.2009.204","article-title":"Autocrine semaphorin 3A signaling promotes glioblastoma dispersal","volume":"28","author":"Bagci","year":"2009","journal-title":"Oncogene"},{"key":"key20180107230423_b23-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"683","DOI":"10.4149\/neo_2013_087","article-title":"The predictive value of sema-phorins 3 expression in biopsies for biochemical recurrence of patients with low- and intermediate-risk prostate cancer","volume":"60","author":"Li","year":"2013","journal-title":"Neoplasma"},{"key":"key20180107230423_b24-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2559.2011.03922.x","article-title":"Expression of class 3 semaphorins and their receptors in human breast neoplasia","volume":"59","author":"Staton","year":"2011","journal-title":"Histopathology"},{"key":"key20180107230423_b25-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2741\/1569","article-title":"Semaphorins in cancer","volume":"10","author":"Neufeld","year":"2005","journal-title":"Front Biosci"},{"key":"key20180107230423_b26-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1172\/JCI0215467","article-title":"Semaphorins as signals for cell repulsion and invasion","volume":"109","author":"Goshima","year":"2002","journal-title":"J Clin Invest"},{"key":"key20180107230423_b27-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"13954","DOI":"10.1073\/pnas.231490898","article-title":"Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B","volume":"98","author":"Tomizawa","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20180107230423_b28-ijmm-35-05-1374","first-page":"2637","article-title":"Semaphorin 3F gene from human 3p21.3 suppresses tumor formation in nude mice","volume":"62","author":"Xiang","year":"2002","journal-title":"Cancer Res"},{"key":"key20180107230423_b29-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1182\/blood-2006-04-014563","article-title":"Loss of inhibitory semaphorin 3A (SEMA3A) autocrine loops in bone marrow endothelial cells of patients with multiple myeloma","volume":"108","author":"Vacca","year":"2006","journal-title":"Blood"},{"key":"key20180107230423_b30-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/CIRCRESAHA.109.210815","article-title":"Inhibition of semaphorin as a novel strategy for therapeutic angiogenesis","volume":"106","author":"Moriya","year":"2010","journal-title":"Circ Res"},{"key":"key20180107230423_b31-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10549-008-0179-y","article-title":"Autocrine semaphorin3A stimulates alpha2 beta1 integrin expression\/function in breast tumor cells","volume":"118","author":"Pan","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"key20180107230423_b32-ijmm-35-05-1374","first-page":"1231","article-title":"Increased class 3 semaphorin expression modulates the invasive and adhesive properties of prostate cancer cells","volume":"30","author":"Herman","year":"2007","journal-title":"Int J Oncol"},{"key":"key20180107230423_b33-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1096\/fj.03-0513fje","article-title":"Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation","volume":"18","author":"Catalano","year":"2004","journal-title":"FASEB J"},{"key":"key20180107230423_b34-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1126\/science.1097545","article-title":"The Semaphorin 4D receptor Plexin-B1 is a GTPase activating protein for R-Ras","volume":"305","author":"Oinuma","year":"2004","journal-title":"Science"},{"key":"key20180107230423_b35-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1038\/nn1596","article-title":"FARP2 triggers signals for Sema3A-mediated axonal repulsion","volume":"8","author":"Toyofuku","year":"2005","journal-title":"Nat Neurosci"},{"key":"key20180107230423_b36-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ccr.2011.05.027","article-title":"miR-30b\/30d regulation of GalNAc transferases enhances invasion and immunosuppression during metastasis","volume":"20","author":"Gaziel-Sovran","year":"2011","journal-title":"Cancer Cell"},{"key":"key20180107230423_b37-ijmm-35-05-1374","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1186\/1756-0500-6-542","article-title":"Evaluating real-time immunohistochemistry on multiple tissue samples, multiple targets and multiple antibody labeling methods","volume":"6","author":"Dubois","year":"2013","journal-title":"BMC Res Notes"}],"container-title":["International Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijmm.2015.2142\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T02:24:22Z","timestamp":1566440662000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijmm.2015.2142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,3,17]]},"references-count":37,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2015,3,17]]},"published-print":{"date-parts":[[2015,5]]}},"alternative-id":["10.3892\/ijmm.2015.2142"],"URL":"https:\/\/doi.org\/10.3892\/ijmm.2015.2142","relation":{},"ISSN":["1107-3756","1791-244X"],"issn-type":[{"value":"1107-3756","type":"print"},{"value":"1791-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,3,17]]}}}